fresenius cats user manual

Infusion Therapy and Transfusion Medicine 2000;27:307-310. 12. Rosolski T, Matthey T, Frick U, Hachenberg T. Blood separation with two different autotransfusion devices: effects on blood cell quality and coagulation variables. Intraoperative autotransfusion in small children: An in vitro investigation to study its feasability. Perioperative blood salvage during surgical correction of craniosynostosis in infants.Ultrafast processing Easy and safe set up The easy, safe set up and automatic functions guarantee fast and safe handling, even in critical situations. Consistently high haematocrit blood collection reservoir Fully automatic procedure for separating patient blood into packed red cells, platelet rich plasma and platelet poor plasma. The emergency wash. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates. Terumo technologies and you. For availability of Terumo products in other regions, please contact the Terumo Sales Office nearest you. For product availability in your region, contact the Terumo Sales Office nearest you. Platelet Gel Books Platelet Gel Articles Platelet Gel Forums Platelet Gel Devices Stem Cell Applications Blood Management New Articles Blood-Related Forums Blood Management Terms Blood Management Jobs Sanibel Symposium Store Products Contact These units are pre-owned and in excellent condition. Please contact us for pricing information. The Fresenius Continuous AutoTransfusion System is also effective in trauma applications. It is possible that some links will connect you to content onlyIn the case of any discrepancy in meaning, the English version is considered official. Thank. The aim of this study was to evaluate the CATSmart Continuous Autotransfusion System wash program performance with small (200 or 700 mL) and large volumes (1,000 mL) of shed blood and to determine non-inferiority of the CATSmart to the C.A.T.

• fresenius cats user manual, fresenius cats service manual, fresenius cats user manual pdf, fresenius cats user manual download, fresenius cats user manual free, fresenius cats user manual 2017.

Sign in Forgot Password. My Bench Close Sign In Not A Member. Sign Up Join MedWrench OK name type Receive Summary Emails. The Fresenius Continuous AutoTransfusion System is also effective in trauma applications. The functional principle of the Fresenius C.A.T.S continuous-action washing chamber ensures high quality of the packed red cells with high hematocrit levels. FORUMS View All (7) Ask a New Question 0 Replies -Costiug 2 months ago 2 months ago Necessity I need Operating (user) Manual and from Service Manual the maintenance Check Sheet to know what is necesary to check to this kind of device.Please help my,thankyou. Reply 0 Replies -Riz 9 months ago 9 months ago Need Service Manual i need service manual for Fresenisu C.A.T.S. Problem is that it is not switching ON. Need circuit Diagram of Power Supply. Does anyone Have the Service Manual for either model of unit so I can determine what all the pm entails. I appreciate that or if you know where to find it on their technical help site?By continuing to browse the site you are agreeing to our use of cookies. Please review our Privacy Policy for more details. All Rights Reserved. The International Journal of Artificial Organs 1996;19:431-434. 3. Brooker RF, Brown WR, Moody DM, Hammon Jr JW, Reboussin DM, Deal DD, Ghazi-Birry HS, Stump DA. Cardiotomy suction: A major source of brain lipid emboli during cardiopulmonary bypass. The Annals of Thoracic Surgery 1998;65:1651-1655. 4. Kincaid EH, Jones TJ, Stump DA, Brown WR, Moody DM, Deal DD, Hammon Jr JW. Processing scavenged blood with a cell saver reduces cerebral lipid microembolization. The Annals of Thoracic Surgery 2000;70:1296-1300. 5. Djaiani G, Fedorko L, Borger MA, Green R, Carroll J, Marcon M, Karski J. Continuous-flow cell saver reduces cognitive decline in elderly patients after coronary bypass surgery. Vascular and Endovascular Surgery 2008;42:32-39. 10. Schulman G. Quality of processed blood for autotransfusion.

It is currently in use today and is the comparison device for their newest device in the product line — CA TSmart system. The CA TSmart system uses a higher resolution camera that monitors th e red blood cell (RBC)-plasma in terface and automati cally adjusts blood an d saline.It also has the capacity to monitor shed blood and PRC HCT thro ugh an in-line sensor. There are thre e wash options similar to the C.A.T.S plus device: a low- volume wash, a smart wash, which is si milar to the high- quality wash of the C. A.T.S plus device, and an emer gency wash. T o improve functi onality of the device, the overa ll footprint is sm aller and has a height-adju stable centrifuge body. User-friendly op tions have also been added in cluding a touch screen inte rface and an auto start proce ssing feature. The primary objective of this study was to evaluate whether the CA TSmart system is non-inferior to the C.A.T.S plus system, in bein g able to produce a mean PRC HCT within a 15% ma rgin of the C.A.T.S plus system and whether the. Secondary ob jectives included the eval uation of washing and concen trating of RBC to produ ce a product within certain par ameters. The se secondary objectiv e parameters are based on the perfo rmance of the predic ate device using stu dies associated with the 510K application for the CATS and C.A.T.S plus devices. They are consistent with the design speci.The FDA requi res manufac- turers of RBC produ cts to demonstrate ysis at the end of storage as part of the product approval pro- cess. This is also a measure of cell viability at the end of storage. The study was granted an Institutio nal Review Board exempti on and was conducted in a laborator y without any patie nt contact or collect ion of protected heal th information. ABO-co mpatible whole blood was poole d together and then di luted to an HCT of approximate ly 20% with isotonic saline to mi mic shed blood that is routi nely collected intra- or post -operatively. T o charac- terize the.

SFinal packed red cell product was analyzed for red blood cell (RBC), white blood cell, and platelet counts; hemoglobin; hemolysis; RBC recovery rates; and elimination of albumin, total protein, and potassium. The mean hematocrit (HCT) after processing with CATSmart and C.A.T.SSe veral methods of blood conserv ation have been establis hed in an effort to reduce or avoid tr ansfusion of allogenic blood during these procedures. Autotransfusion, also known as cell salvage, is one of those methods and involves re cycling the patien ts shed blood from the surgical field (3). The blood is anti coagulated, collec ted into a reservoir, washed, and concentrated into a transfusable packed red cell (PRC) unit. Cell salvage has become a valuable re source in the operatin g arena as it may minim ize or eliminate th e need for allogenei c blood transfusion and its associat ed risks (4). First-gen eration cell salvage syst ems use a Latham bowl for centrifugation of shed blood and operate discontinu- ously. The Food and Drug Admini stration (FDA) cleare d the.This type of device is used during surgical procedures in which shed whole blood is collected from the surgical.This blood is concentrat ed and washed into a PRC unit for reinfusi on. Reported adva ntages of the CA TS continuous syst em over discontinuous Latham bowl-type systems include the ability to remove lipids from the shed blood and the ability to obtain a consistently higher concentrated PRC product (5). During the wash ing process, shed bl ood is suspended with Received for publication June 24, 2016; accepted October 18, 2016. Address correspondence to: Edmund H. Jooste, MBChB, Division of Pediatric Anesthesiolog y, Department of Anesthesiology, Duke University Medical Center, 2301 Erwin Road, Durham, NC 27710. They developed methods, conducted training, and tested chemistry. 107 The washed blood is concentrated to a.

Differences in secondary outcomes between the two systems show ed generally small clinical ly irrelevant, but statistica lly signi. Nine paired te sts were evaluated us ing a starting volume of 700 mL an d an HCT of 20 %. Smart Wash Nine paired te sts were evaluated u sing a starting volume of 1,000 mL and an HCT of 20 %.DISCUSSION The salvage of shed blood during surgical procedures has been recognized as an important component to hospital blood conservation programs (7). However, it has been well recognized that the quality of processed salvaged blood is quite vari able (2,5). The RBC recovery rate and washing ef.Shulman examined the ef.He reported that continu- ous.The perfor- mance was tested when three different processing programs were used on small and large aliquots of shed blood. All objectives, primary and secondary, were met. The paired procedures conducted for evaluation of the CA TSmart, as well as C.A.T.S plus systems demonstrated reliable operation and function of RBC recovery, concen- tration, and washing. The evaluations used the lower end of acceptable blood volume for operation and expected use of the device. The RBC recovery and concentration functions were measured by.A mean RBC recovery rate of 85.4% and a mean HCT of 59.6% were identi ? ed across all wash programs evaluated. Of all wash programs evaluated, the smart wash revealed the highest RBC recovery rate of 91.1% and mean HCT of 63.9%. Conversely, the wash with the lowest mean rate of RBC recovery and HCT was the low-volume wash (200 mL) with 71.0% and 55.8%, respectively. Under this wash program, two procedures resulted in HCT low-volume wash (200 mL) with 20% HCT represents 40 mL of RBCs, which app roaches the minimal RBC volu me the device can ef.The results demonstrate an ef.This is important in the operating room, as irriga- tion.As the centrifuge spins, soluble blood components are sepa- rated from form ed cellular bodies (RBC, WB C, PLT s) and removed ( 9).

Add itional testing was conduc ted at hours 6 and 24 to measure hemoly sis during storage. Spun HCT s were tested using manual met hods. Complete blood counts were conducted using the KX- 2ln Hematology Analyzer (Sysmex, Lincolnshire, IL) at Duke University and Fresenius Kabi, and the XN Hematology Analyzer (Sysmex) at Maine Medical Center. Clinical chemistry testing was centralized using the AU400e (Olympus, Tokyo, Japan). The data from previous validation studies performed showed a mean HCT of 56.8% for the CA TSmart system and a mean HCT of 57.0% for the C.A. T.S plus system, with a maximum SD of 7.1. The on e-sided 95% chi- squared con.A total of 27 sample pairs were us ed for an equal distribu- tion among wash progr ams. Furthermore, to eval uate the performanc e of the device and qualit y of product when minimal shed blo od is processed, nine sample pa irs were added to eval uate the 200-mL low-v olume wash program. This brought the to tal number of needed paired test s to 36 for the study. Standard summary statistics ( N, mean, SD, median, minimum, and maximum) are reported for all measures. Non-infer iority testing was carr ied out evaluating th e new sample agai nst a 15% decrease in the p rimary outcome, spun HCT using a t test only.One pair was not evaluable after a PRC sensor error, meaning 37 paired tests were processed completely and available for review. The one non-evaluable procedure occurred on the CA TSmart device due to an instrument failure, caused by a PRC failure alarm. This was likely due to a misaligned label on the disposable, which is a known issue and ha s been corrected. Table 2 demon- strates the no n-inferiority of th e CATS mart system at 15% margin whe n compared to the C.A. T.S plus system with ar e s u l t i n g p value lts in Tables 3 an d 4, all washes ar e evaluated on the seco ndary ef.Hemolysis values are found in Table 5.

Three separate autotransfusion devices were selected for evaluation. Each of the autotransfusion devices were used to collect salvageable blood from the surgical field as well as to process residual blood from the cardiopulmonary bypass circuit after decannulation. The cell salvage process was performed in accordance with the manufacturer’s instructions for use and the recommended settings for processing and washing. The Sorin Xtra device had the 55 mL bowl set up for all cases, while the Fresenius continuous autotransfusion systems utilized the standard disposable for each device. The Continuous Autotransfusion System Smart tended to produce the highest hematocrit product, ranging from 44 to 81%. Discussion. Through this evaluation, it was determined the continuous autotransfusion systems provided the highest hematocrit with the lowest recovered packed red cell volume, while the Sorin Xtra packed red cell product showed to have a lower hematocrit with a larger packed red cell volume. Each device proved effective within our pediatric population. View Show abstract Blood clot formation in reinfusion bag with CATSmart: Two case reports Article Jun 2019 INT J ARTIF ORGANS Jun Hyun Kim Ja Young Bae Sang Il Lee Ji Yeon Kim Autologous blood cell salvage reduces the need for postoperative allogeneic blood transfusion and alleviates immunologic reactions, so the technique is commonly used in cardiac surgery. The continuous autotransfusion system is a type of blood cell salvage device. Although the processing program of continuous autotransfusion system includes filtering of several materials from suctioned blood, such as clots, leukocytes, cytokines, and complement, we identified some unexpected blood clots in the reinfusion bag. Pathologic examination revealed that the clots were composed of fibrin, red blood cell aggregates, and histiocytes. We report two cases of these abnormal findings during the use of CATSmart in cardiac surgery.

View Show abstract 2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines Article Full-text available Mar 2011 Vic Ferraris Jeremiah R Brown George Despotis Kenneth G Shann Practice guidelines reflect published literature. Because of the ever changing literature base, it is necessary to update and revise guideline recommendations from time to time. The Society of Thoracic Surgeons recommends review and possible update of previously published guidelines at least every three years. This summary is an update of the blood conservation guideline published in 2007. The search methods used in the current version differ compared to the previously published guideline. Literature searches were conducted using standardized MeSH terms from the National Library of Medicine PUBMED database list of search terms. The following terms comprised the standard baseline search terms for all topics and were connected with the logical 'OR' connector--Extracorporeal circulation (MeSH number E04.292), cardiovascular surgical procedures (MeSH number E04.100), and vascular diseases (MeSH number C14.907). Use of these broad search terms allowed specific topics to be added to the search with the logical 'AND' connector.

Over all potassi um, PLT and WBC elimination data were also obtained and found to be 92.1%, 78.0%, and 34.7%, resp ectively. The WBC elimination was dete r- mined to be 34.7 % and under special cond itions in which it would be clin ically advantage ous to leuko reduce th e RBC product, a leu kocyte reducing.T otal protein and al bumin elimination ra tes were excellent and measured 97.1 % and 97.6%, respec tively. Th e smart wash, as expected, de monstrated the highest el imination rates of protein and al bumin of 98.9% and 99.1 %, respectively, whereas the emer gency wash had a slightly lo wer elimina- tion rate of total protein and albumin of 94.4% and 95.1%, respectively. This ? nding is important as the product from an emergency wash is still excellent, while the processing time is far less than that of the smart wash, 9.3 minutes to 16 minutes, respectively. Viability of the RBC collected over time is also impor- tant. Overall, very low levels of hemolysis were identi.Hemolysis testin g was conducted at ho urs 6 and 24 because the dev ice can be used for both intra- and post-operative shed blood collections. Post-operativ e shed blood can be stored for up to 6 h ours after processin g (10). Therefore, to assess product acceptability for both intra- and post- operative conditions, hemolysis at those speci.There are a number of improved functionalities in the CA TSmart. It has a quieter motor, the height-adjustable body and overall smaller footprint allows the CA TSmart device to better.The touch scre en display, which can be used with gloved hands, has a quick start option which is help ful when rapid proce ssing of shed blood is neces sary. In addi - tion, the autost art processing feat ure allows the operator to focus on the p atient, not the device, generating a safety bene.Regardless of the wash program used, cells are ef.The study also con.

All secondary objectives — RBC recovery rate, plasma and to tal protein elimin ation, and hemolys is after 24 hours — were al so achieved. This study demo nstrated that the CA TSmart and C.A.T.S plus systems produ ce a high-qual ity PRC product, even when volume s as small as 200 mL are processed using th e low-volume wash program. Overall, the enhancements to the CA TSmart system, along with the study results, make it a viable addition to any insti- tution using blood conser vation and cell salvage. REFERENCES 1. Moskowitz DM, Klein JJ, Shander A, et al. Predictors of transfusion requirements for cardiac surgical procedures at a blood conservation center. Perioperative blood transfu- sion and blood conservation in cardiac surgery: The Society of Tho- racic Surgeons and the Society of Cardiovascular Anesthesiologists clinical practice guideline. Intraoperative autotransfusion. Standards for Perioperative Autologous Blood Collection and Administration, 6th ed.; Bethesda, MD: AABB.The use of cell salvage and autologous blood transfusion has become an important method of blood conservation. So far, there are no clinical data about the performance of the continuous autotransfusion device CATSmart. Methods. In total, 74 patients undergoing either cardiac or orthopedic surgery were included in this prospective, bicenter and observational technical evaluation to validate red cell separation process and washout quality of CATSmart. Results. Conclusion. The new autotransfusion device enables sufficient red cell separation and washout quality. State of art. Review Article Jan 2019 A.Yu. Lubnin V.V. Gromova View Comparison of three autotransfusion devices for utilization in the pediatric population Article May 2020 Perfusion Richard Melchior Molly Dreher Brandon Shade Tami Rosenthal Introduction. A device that may help attenuate the amount of homologous blood product given to pediatric cardiac surgical patients is the autotransfusion device.

In this 2011 guideline update, areas of major revision include: 1) management of dual anti-platelet therapy before operation, 2) use of drugs that augment red blood cell volume or limit blood loss, 3) use of blood derivatives including fresh frozen plasma, Factor XIII, leukoreduced red blood cells, platelet plasmapheresis, recombinant Factor VII, antithrombin III, and Factor IX concentrates, 4) changes in management of blood salvage, 5) use of minimally invasive procedures to limit perioperative bleeding and blood transfusion, 6) recommendations for blood conservation related to extracorporeal membrane oxygenation and cardiopulmonary perfusion, 7) use of topical hemostatic agents, and 8) new insights into the value of team interventions in blood management. Much has changed since the previously published 2007 STS blood management guidelines and this document contains new and revised recommendations. View Show abstract Perioperative Blood Transfusion and Blood Conservation in Cardiac Surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline Article Full-text available Jun 2007 Vic Ferraris Suellen P. Ferraris Sibu Saha Simon C Body A minority of patients having cardiac procedures (15% to 20%) consume more than 80% of the blood products transfused at operation. Blood must be viewed as a scarce resource that carries risks and benefits. A careful review of available evidence can provide guidelines to allocate this valuable resource and improve patient outcomes. We reviewed all available published evidence related to blood conservation during cardiac operations, including randomized controlled trials, published observational information, and case reports. Conventional methods identified the level of evidence available for each of the blood conservation interventions. Review of published reports identified a high-risk profile associated with increased postoperative blood transfusion.

Six variables stand out as important indicators of risk: (1) advanced age, (2) low preoperative red blood cell volume (preoperative anemia or small body size), (3) preoperative antiplatelet or antithrombotic drugs, (4) reoperative or complex procedures, (5) emergency operations, and (6) noncardiac patient comorbidities. Careful review revealed preoperative and perioperative interventions that are likely to reduce bleeding and postoperative blood transfusion. Preoperative interventions that are likely to reduce blood transfusion include identification of high-risk patients who should receive all available preoperative and perioperative blood conservation interventions and limitation of antithrombotic drugs. Perioperative blood conservation interventions include use of antifibrinolytic drugs, selective use of off-pump coronary artery bypass graft surgery, routine use of a cell-saving device, and implementation of appropriate transfusion indications. An important intervention is application of a multimodality blood conservation program that is institution based, accepted by all health care providers, and that involves well thought out transfusion algorithms to guide transfusion decisions. Based on available evidence, institution-specific protocols should screen for high-risk patients, as blood conservation interventions are likely to be most productive for this high-risk subset. View Show abstract Processing of small volumes in blood salvage devices Article Jul 2014 Transfusion Timo Seyfried Anita Breu Michael Andreas Gruber Ernil Hansen Background. New technical developments such as a small Latham bowl, a continuous autotransfusion system, and a dynamic disk designed for postoperative autotransfusion raise hopes for a possible application of blood salvage in young children. However, the minimal blood volume for effective processing under clinically relevant conditions has yet to be determined.Study Design and Methods.

Fresh blood from volunteer donations adjusted to a hematocrit (Hct) of 10% was used to test ELECTA (Sorin) equipped with a 55-mL bowl, C.A.T.S (Fresenius) in the pediatric program mode, and OrthoPAT (Haemonetics). Twenty-milliliter portions of red blood cells (RBCs) were added and processed under various conditions, including clinically relevant first filling and intermittent emptying. RBC recovery and availability and plasma elimination were calculated from the Hct, free hemoglobin, and total protein.ResultsThe main impediment to recovery and availability was the first filling. There, RBC recovery was significantly reduced, while it subsequently varied between 93 and 98%. To produce the first 30 mL of RBCs, ELECTA required 42 mL and C.A.T.S and OrthoPAT 62 mL owing to the dead space of the separation chamber or reservoir, respectively. RBC availability was much higher in subsequent processes, with only minimal differences between the three devices. They all consistently provided high plasma elimination rates.Conclusion. The continuous system showed no advantage over a small Latham bowl. From the results it can be calculated that the limit for feasible cell salvage at present is an infant of 6 months. All three devices are suitable for the processing of small volumes, but have the scope for further optimization. View Show abstract Washing of banked blood by three different blood salvage devices Article Aug 2012 Transfusion Michael Andreas Gruber Anita Breu Melanie Frauendorf Ernil Hansen BACKGROUND: Storage lesions in red blood cells (RBCs) lead to an accumulation of soluble contaminants that can compromise the patient. Organ failures, coagulopathies, and cardiovascular events including lethal cardiac arrest have been reported, especially with massive transfusion or in pediatric patients.

Washing improves the quality of stored RBCs, and autotransfusion devices have been proposed for intraoperative processing, but these devices were designed for diluted wound blood, and limited data on their performance with RBCs are available. STUDY DESIGN AND METHODS: Three autotransfusion devices (Electa, Sorin; CATS, Fresenius; OrthoPAT, Haemonetics) differing in function of their centrifugation chambers were evaluated with RBCs at the end of their shelf life and with dilutions thereof. Elimination rates of potassium, plasma free hemoglobin, total protein, citrate, acid equivalents, and iomeprol added as a marker substance were analyzed, in addition to RBC recoveries. RESULTS: Product hematocrit (Hct) levels ranged between 54.8 and 72.6%. RBC recovery rates were between 62.7 and 95.0%, the lowest being with the OrthoPAT processing of undiluted RBCs. Plasma elimination rates increased with predilution and ranged from 46.6% to 99.5%, the lowest being with the CATS and undiluted RBCs. Washing did not change pH and buffering capacity of RBCs. CONCLUSION: Autotransfusion devices offer a practical and obviously economical option to wash banked RBCs intraoperatively to prevent hyperkalemia and other disturbances in massive transfusion or pediatric patients. Predilution improves elimination rates, especially in devices that produce high product Hct levels. With a Y-tubing the RBCs should bypass reservoir and vacuum, and the procedure should be guarded by a policy and procedure manual and a quality management system. View Show abstract Intraoperative autotransfusion. Experience in 725 consecutive cases Article Jun 1983 ANN SURG MARIE M. KEELING Laman A. Gray MARY A. BRINK Kirby Bland Autologous intraoperative transfusion employing the Haemonetics Cell Saver is reported in 725 patients from a general hospital population, of which 75% were cardiovascular patients.

The remaining cases included various orthopedic procedures, splenectomy, craniotomy, ectopic pregnancies, Caesarian sections, and exploratory laparotomy. On occasion, this method was utilized in trauma and in pediatric surgery. In 100 consecutive open heart procedures operated prior to the Cell Saver period, an average of 1.97 units of bank blood was utilized during operation, as compared with 0.75 units in 100 consecutive cases studied employing the Cell Saver (p less than 0.0001). Homologous blood utilization during cardiac surgery declined more than 50% with the use of the Cell Saver. Quality control was monitored scrupulously and included special precautions against air embolism, abnormal coagulation, and sepsis. The overall mortality rate was 2.8%, and in no instance was mortality or morbidity ascribable to the autologous transfusion. Numerous advantages offered by autotransfusion include prevention of sensitization of the recipient to various antigens in donor erythrocytes, leucocytes, platelets, and plasma, and avoidance of transfusion-transmitted diseases, especially viral hepatitis. Additionally, autologous blood, the only perfectly compatible product, provided immediate availability while conserving blood bank resources. In circumstances in which the intraoperative blood loss exceeded 1000 cc in the adult, its use was observed to be cost-effective. In the present study, autotransfusion proved safe, efficient, and in some instances life saving. View Show abstract Fat Elimination During Intraoperative Autotransfusion Article Dec 1997 ANESTH ANALG Michael Booke Manfred Fobker Debi Fingerhut Hugo Van Aken Unlabelled. Intraoperative autotransfusion of scavenged blood is an established method to reduce the need for perioperative homologous blood transfusion. However, if fat particles contaminate blood suctioned from the wound site, no reliable method is available to remove them during the washing and concentration of the recycled blood.